Paraprobiotics and Postbiotics of Probiotic Lactobacilli, Their Positive Effects on the Host and Action Mechanisms: A Review

Lactobacilli comprise an important group of probiotics for both human and animals. The emerging concern regarding safety problems associated with live microbial cells is enhancing the interest in using cell components and metabolites derived from probiotic strains. Here, we define cell structural components and metabolites of probiotic bacteria as paraprobiotics and postbiotics, respectively. Paraprobiotics and postbiotics produced from Lactobacilli consist of a wide range of molecules including peptidoglycans, surface proteins, cell wall polysaccharides, secreted proteins, bacteriocins, and organic acids, which mediate positive effect on the host, such as immunomodulatory, anti-tumor, antimicrobial, and barrier-preservation effects. In this review, we systematically summarize the paraprobiotics and postbiotics derived from Lactobacilli and their beneficial functions. We also discuss the mechanisms underlying their beneficial effects on the host, and their interaction with the host cells. This review may boost our understanding on the benefits and molecular mechanisms associated with paraprobiotics and probiotics from Lactobacilli, which may promote their applications in humans and animals.


INTRODUCTION
The genus Lactobacillus is the largest genus among lactic acid bacteria (LAB), consisting of more than 237 species (1), with continuous new species discoveries, such as Lactobacillus metriopterae (2) and Lactobacillus timonensis (3). Some Lactobacillus species are among the most widely used probiotics (4). Accumulating evidences are proposing that probiotic cell components or metabolites which interacting with the host cells may trigger probiotic effects (5)(6)(7)(8)(9). The advantages of metabolites and cell components of these probiotic bacteria over probiotic bacteria were clarified (10, 11). Furthermore, it has been reported that not all probiotic bacteria are safe. Concerns associated with live probiotic bacteria administration have been described in case reports, clinical trials and experimental models (12)(13)(14). Therefore, the applications of cell components or metabolites derived from probiotic strains are gaining more interest.
Regarding the use of cell components and metabolites of probiotics, different terms have been proposed, such as "paraprobiotics, " "ghost probiotics" "inactivated probiotics" "non-viable microbial cells, " "metabolic probiotics" "postbiotics, " etc. The concept of paraprobiotics was proposed to indicate the use of inactivated microbial cells or cell fractions that confer health benefit to the host (15). In some studies, cell wall components of the probiotics are categorized as paraprobiotics (16). Postbiotics are defined as soluble products or metabolites secreted by probiotics that have physiological benefits to the host (9). Similar definition as "factors resulting from the metabolic activity of a probiotic or any released molecules capable of conferring beneficial effects to the host in a direct or indirect way" was made by other researchers (17). To better differentiate cellular structural components and metabolites of probiotic strains, we define the cell structural components (mainly cell wall components) as paraprobiotics and secretory metabolites/componnets as postbiotics in this review.
The potential health benefits of probiotic Lactobacillus species isolated from the intestine of humans and animals have been documented in a plethora of research publications to date. The terms of paraprobiotics and postbiotics have emerged recently, but they have been adopted rapidly in several study areas including food science, food microbiology, and health and nutrition of human and animals. However, knowledge on the types of paraprobiotics and postbiotics is limited and some aspects related to the bioactivities and the action mechanisms of health-promoting effects of paraprobiotics and postbiotics remain unclear. The present review aims to update the evidence on the paraprobiotics and postbiotics derived from Lactobacilli, their physiological benefits and mechanism of interaction with the host cells.

ISOLATION AND PURIFICATION OF PARAPROBIOTICS AND POSTBIOTICS
Scientific evidences showed that there are different methods to isolate and purify paraprobiotics and postbiotics from several Lactobacilli species. Isolation of paraprobiotics and postbiotics from different probiotic bacteria involve cell disruption techniques including thermal treatment (18,19), enzymatic treatments (60), solvent extraction (20), radiation (ionizing and UV rays) (21), high pressure (22) and sonication (23-26). Several other methods also have the potential to be used for production of paraprobiotics and postbiotics, such as ohmic heating and supercritical CO 2 , drying, pulsed electric field (PEF), and pH changes (27).
During the production of paraprobiotics from probiotics, it is important to expose the cells to factors (27) without disrupting cell structure (9). On the other hand, to isolate intracellular postbiotics, it is required to disrupt the bacterial membrane via combined treatments in order to obtain the intracellular metabolites (9). Furthermore, extraction and clean-up steps have been applied to help the isolation procedures, such as centrifugation, dialysis, lyophilization and column purification (23, 28-30). Secreted postbiotics by viable cells can be recovered from supernatants, and the viable cells can be eliminated from the medium by centrifugation and/or filtration (31). In most of the time, we can isolate paraprobiotics and postbiotics. However, in some cases it is difficult to separate them, and additional steps such as microfiltration are necessary to isolate the postbiotic fraction. The choice of techniques for isolation of postbiotics and paraprobiotics depend on the characteristics of molecules under study (32). Since the health benefits of paraprobiotics and postbiotics are influenced by their isolation methods, it is important to select the best methods and conditions for probiotic inactivation to obtain paraprobiotics and postbiotics (33).

CATEGORIES, PROPERTIES, AND POSITIVE EFFECTS OF PARAPROBIOTICS AND POSTBIOTICS DERIVED FROM LACTOBACILLUS
Studies described that most of the paraprobiotics are located in the bacterial cell-envelope (5,34). Generally, paraprobiotics consist of a wide range of molecules including peptidoglycans, surface proteins, cell wall polysaccharides, while postbiotics include secreted proteins and peptides, bacteriocins, organic acids, etc (10, 35-37). Furthermore, the paraprobiotics and postbiotics mediate a wide range of positive effects on the host such as immunomodulatory, anti-tumor, barrierpreservation, and antimicrobial properties (24, 38). Different species of Lactobacillus have different types of paraprobiotics and postbiotics. In the following part, we summarized the chemical composition and beneficial functions of paraprobiotics and postbiotics derived from Lactobacilli ( Table 1).

Teichoic Acid
Teichoic acids (TAs) are the second main constituent of cell walls of Lactobacilli and account for up to half of the cell wall dry weight (110). Due to the anionic polymers nature of the TA, it can be covalently linked to peptidoglycan as wall teichoic acid (WTA) or anchored to the cytoplasmic membrane by their lipid anchors as lipoteichoic acid (LTA) (111).
Plethora studies reported the immunomodulatory characteristics of TA from many species of Lactobacillus (112). L. plantarum LTA (Lp.LTA) attenuated the expression of IL-8 induced by Pam2CSK and exerted anti-inflammatory effects on human intestinal epithelial cells (92). LTA of L. plantarum also showed anti-inflammatory responses in porcine intestinal epithelial cells (7). The anti-inflammatory functions and effects of LTAs are species or strain-specific. For instance, it has been shown that the majority of immunomodulatory properties induced by L. plantarum TA were dependent on D-alanylation (93).

Cell-Wall Polysaccharides
Polysaccharides are common in gram-positive bacteria surface including Lactobacilli. The most studied polysaccharides are exopolysaccharides (EPS). EPS may facilitate the interaction of the bacteria with the environment, mediate adhesion properties, protect against pathogens, and also act as a protective layer (43,113).
delbrueckii (L. delbrueckii) subssp. bulgaricus OLL1073R-1 induced interferon gamma (IFN-γ) production and activated natural killer (NK) cells in mice (102), which contributed to anti-viral infection effect (114). EPS can also regulate the energy metabolism of host. The EPS isolated from L. rhamnosus GG inhibited adipogenesis, and deceased the level of triacylglycerols and cholesterol ester in the liver and serum in mice (115).
Besides to the immunoregulatory effect of EPS, studies also described their anti-tumor abilities. In vitro anti-tumor assay of the EPS from L. plantarum YW32 proved their powerful inhibitory activity against colon cancer HT-29 cells (63). EPS isolated from Lactobacillus acidophilus 20079 strain can regulate both apoptotic and nuclear factor kappa B (NF-κB) inflammatory pathways in human colon cancer and have a potentiality to upregulate the expression of IKbα, P53 and TGF genes (103). EPSs extracted from L. casei M5, L. casei SB27, L. casei X12, and L. casei K11 strains suppressed HT-29 cell growth via induction of G0/G1 cell cycle arrest and apoptosis (104). EPS from L. plantarum NCU116 induced c-Jun dependent Fas/Fasl-mediated apoptosis via TLR2 in mouse CT26 cells (105). Moreover, EPS from L. acidophilus inhibited the expressions of genes involved in tumor angiogenesis and survival of the colon cancer cell lines in vitro (106). Similarly, EPS from L. acidophilus LA1 demonstrated their anti-tumor activity in vivo against Ehrlich ascites carcinoma cells by suppressing the serum levels of malondialdehyde and nitric oxide (116) and EPS of Lactobacillus gasseri strains also showed their capability to inhibit cervical cancer cell growth and modulate immune response (117).

Cell Surface Proteins
Surface layer proteins are one of the most important components of the outermost cell envelope structures on Lactobacilli cell surface and other probiotic bacteria species. Cell surface proteins are classified as the proteins which are covalently or noncovalently attached to the cell surface. Recent study indicated that many types of surface proteins including LPXTG proteins, S-layer proteins, pili proteins, moonlight proteins are produced by Lactobacillus species including L. plantarum, L. rhamnosus, Lactobacillus helvetics (L. helveticus), and L. acidophilus (118). These proteins play significant positive roles on the host biological processes.

LPXTG PROTEINS
LPXTG protein is one of the proteins covalently attached to the peptidoglycan of bacterial cell wall. These proteins contain a C-terminal LPXTG signal, and are linked to the cell wall by sortase A (SrtA). In Lactobacilli, LPXTG proteins are among the best-known covalent anchored surface proteins. LPXTG proteins were found in many Lactobacillus species including L. plantarum WCFS1, L. johnsonii NCC533, Lactobacillus sakei (L. sakei) 23K and L. salivarius UCC118 (119).
LPXTG proteins from different Lactobacillus species have been shown to bind to mucus and epithelial cells, and play major roles in bacteria-host interaction (120). About 12 proteins containing LPXTG motifs were identified from L. plantarum, which were involved in adhesion activity (120)(121)(122). Their major role was adherence to collagen, fibronectin, chitin, or mucus (123). Furthermore, studies with SrtA mutants of L. casei BL23 suggested that SrtA-dependent proteins participated in adhesion of this strain to Caco-2 and HT29 cells (69).

S-LAYER PROTEINS
Many Lactobacilli strains, including Lactobacillus cripatus (L. crispatus) ZJ001 and JCM 5810, L. acidophilus ATCC 4356, Lactobacillus buchneri (L. buchneri) CD034, and Lactobacillus brevis ATCC 8287, display a surface coating made of a crystalline, glycoprotein subunits also known as the S-layer (121). S-layer proteins are mostly anchored to peptidoglycan by non-covalent bonds (124). S-layer proteins of Lactobacilli account about 15% of total cell wall proteins and they differ from counterparts of other bacteria in their smaller size (25-71 kDa) and higher isoelectric point values (9.4-10.4) (125). In some species of Lactobacillus, Slayers with distinctive features can be found, such as glycosylated S-layers in L. buchneri and Lactobacillus kefiri (L. kefiri) (96).
Adhesive S-layers proteins of probiotic Lactobacilli can inhibit adherence and infection of pathogenic bacteria. S-layer proteins isolated from Lactobacilli were shown to bind to host cell proteins and extracellular matrix (44, 126). The S-layer protein from L. kefiri CIDCA 8348 improved the response of macrophages to lipopolysaccharide (LPS) (125) and was able to enhance the ovalbumin-specific immune response by triggering maturation of antigen presenting cells through the recognition of glycan moieties in mice (127). Lactobacillus paracasei subp. paracasei, L. rhamnosus, and L. casei strains isolated from natural dairy products are able to inhibit Shigella sonnei adhesion to HT-29 cells via their S-layer proteins (128). Similarly, the S-layer proteins from L. helveticus fb213, L. acidophilus fb116 and L. acidophilus fb214 contributed to the adhesion of the Lactobacillus strains to HT-29 cells and helped to inhibit the adherence and invasion of E. coli ATCC 43893 (96). S-layer proteins of Lactobacillus have also been demonstrated to competitively bind the intestinal epithelium in vivo and inhibit pathogen infection (97,98).

PILI PROTEINS
Pili are elongated protein structures protruding outside bacterial cells. Initially pili were considered as special features of pathogens (129), until they were found in L. rhamnosus. Pili bind to the intestinal mucusa and promote persistence of Lactobacillus strains in GI tract (130,131). The SpaCBA pili of L. rhamnosus GG were a binding factor to human intestinal mucus, collagen, and intestinal epithelial cell (IEC) lines (46), and SpaC was credited as the major adhesion determinant (71,107).
Studies also suggested other beneficial effects of pili derived from Lactobacillus strains. Mutant of L. rhamnosus GG devoid of SpaC induced increased mRNA expression of the proinflammatory cytokines IL-8 and TNF-α in Caco-2 cells while wild-type L. rhamnosus GG or SpaC alone had little impact on cytokine production (46). The immunomodulatory effect of SpaC was also observed in human fetal intestinal epithelial cell line H4 by modulating TLR-related gene expression (47). Comparative analysis of L. rhamnosus GG wild-type and isogenic pili mutants have shown immunoregulatory function of pilli by interactions with monocytes and dendritic cells (46,48). Similar comparison also demonstrated that pilli can promote pathogen exclusion including pilliated Enterococcus faecium (132). Furthermore, SpaCBA pilli have been reported to be involved in promotion of cell proliferation in intestinal crypts, and protection against radiological insults (133). The SpaC pilin of L. rhamnosus GG (LGG) has been confirmed to induce the generation of reactive oxygen species (ROS) in epithelium and play a role in stimulating ERK phosphorylation and protecting the gut's epithelial barrier (133).
Moonlighting proteins can mediate the colonization of the probiotic strains in intestinal tract. L. acidophilus used surface GAPDH to colonize the gut (142). Lactobacillus species including L. plantarum, Lactobacillus fermentum (L. fermentum), and L. jensenii were found to use moonlighting proteins in competitive exclusion and displacement of pathogens (140). Furthermore, moonlighting proteins including GAPDH, enolase and EF-Tu were involved in plasminogen/plasmin binding and activation (143), which might interfere with the exploitation of plasminogen by gastrointestinal pathogens that express plasminogen receptors or activators, such as Helicobacter pylori and Salmonella sp. (144).

Postbiotics
As postbiotics, different secretory components of probiotic Lactobacillus strains have been reported to mediate beneficial effects, including proteins, peptides, organic acids, and other small molecules. These components can be secreted by live bacteria or released into the host environment after bacteria lysis and confer various physiological benefits to the host.

Secreted Proteins and Peptides Protein p40 and p75
Protein p40 and p75 were identified from many Lactobacilli species including L. casei, L. paracasei, and L. rhamnosus (145). They are secreted cell wall muramidases and have approximately molecular sizes of 40 and 75 kDa, respectively (74). The positive contribution of these proteins secreted from Lactobacillus species has been described in several studies. The protein p40 from L. rhamnosus GG showed an immunomodulatry action in mice (74). The p40 transactivated the epidermal growth factor receptor (EGFR) in intestinal epithelial cells, inhibited apoptosis and preserved barrier function in the colon, thereby ameliorating intestinal injury and inflammation (17, 75,76,78,109). Besides, p75 purified from L. rhamnosus GG and L. casei BL23 have anti-apoptotic activity by inducing the EGF/Akt pathway (145). Furthermore, the p40 and p75 proteins were able to protect the intestinal epithelial tight junctions and barrier functions by a protein kinase (PKC) and MAP kinase-dependent mechanism (76).

Aggregation-promoting factor (APF)
Lactobacillus species have been reported to secrete a number of aggregation promoting factor (APF) proteins, which are extracellular proteins responsible for bridging of conjugal pairs, self-aggregation, maintenance of cellular shape, and co-aggregation with other commensal or pathogenic bacteria (73,82).
The function of APF from Lactobacilli mainly involves host colonization and pathogen exclusion. Previous studies demonstrated that L. gasseri SBT2055 decreased adhesion and invasion of Campylobacter jejuni (C. jejuni) in vitro and hindered its infection in chickens via co-aggregation with the pathogens, and the co-aggregation was mediated by proteinaceous cellsurface components (79). Similarly, Yungareva and Urshev (81) also confirmed that APF in Lactobacillus delbr (L. delbr). subspp Bulgaricus had co-aggregation property which inhibited the growth of pathogenic bacteria. APF-2 from L. gasseri ATCC 9857 strain contributed to inhibition of the adhesion of Trichomonas vaginalis to human vaginal ectocervical cells (80,81). Furthermore, the presence of high concentration of intracellular GGDEF protein (DgcA) in L. acidophilus and a serine/threonine-rich APF protein from L. plantarum NCIMB 8826 resulted in increased production of EPS and enhanced the co-aggregation ability (82,83). The aggregation phenotype enables Lactobacilli strains to colonize the GI tract, and to inhibit adhesion of pathogens by competitive exclusion or by co-aggregation with pathogens (62,146).

Bacteriocins
Bacteriocins are a class of powerful small ribosomally synthesized antimicrobial peptides with bactericidal or bacteriostatic functions (147). Various types of bacteriocins were produced by Lactobacilli species, such as lactacin B from L. acidophilus and L. johnsonii, lactocin from L. casei, Lactocin 705 from L. casei, Lactoccin G from L. lactis and plantaricin from L. plantarum (148,149).
Bacteriocins of probiotic Lactobacilli can mediate inhibitory effect against pathogens. Bacteriocin PJ4 produced by L. helveticus PJ4 isolated from rat gut microflora was active against enteric pathogen (88) and bacteriocin DT24 produced by vaginal L. brevis DT24 was antagonistic against uropathogenic E. coli (89). Pangsomboon et al. (150) reported that bacteriocins from L. paracasei were able to kill P. gingivalis. Moreover, the bacteriocin extracted from probiotic L. acidophilus KS40 was able to inhibit urogenital pathogens such as Gardnerella vaginalis, Streptococcus agalactiae, and Pseudomonas aeruginosa (90). Reuterin produced by L. reuteri (6) exerted antimicrobial effects by modifying thiol groups and inducing oxidative stress in bacterial cells (151). L. salivarius UCC118, a probiotic strain of human origin, produced bacteriocin Abp118, which mediated the inhibitory effect of the probiotic against Listeria monocytogenes infection in mice (91). Additionally, purified bacteriocins from different Lactobacillus species have shown anti-infective functions in mice models, demonstrating that bacteriocins can be a promising alternative against gastrointestinal infections (152).
Besides the antimicrobial effects, bacteriocins produced by Lactobacillus may also affect host immunity. Plantaricin was identified as the factor in L. plantarum WCFS1 that modulate the immune response of DCs (84). Notably, plantaricin can be produced during L. plantarum WCFS1 colonization in mice, thus supporting the function of this bacteriocin under in vivo conditions (85). Phagocytosis activities of macrophage were improved by bacteriocins isolated from L. acidophilus (87). Moreover, bacteriocins can affect the immune function of the host by selectively competing with specific bacterial strains and shaping the microbiota composition (9, 86).

Small Molecules
Small molecules differ from the above mentioned paraprobiotics and protein/peptide postbiotics in that they do not have strain-specific differences in the biochemical characteristics and therefore are generally not responsible for strain-specificity of probiotic functionality. Moreover, different from protein/protein postbiotics, they can be produced by strategies independent of the probiotic strains. However, subsets of the probiotic effects are mediated by small molecules. Therefore, in this review, we also categorized small molecules as postbiotics, and summarized their beneficial effects.

Short chain fatty acids
SCFAs are produced by gut microbiota from indigestible food components such as fiber, oligosaccharides and polysaccharides via different metabolism channels (153,154). The SCFAs have a wide range of positive effects on the host, such as providing energy sources for colonic epithelium cells (155), maintaining metabolic homeostasis (156), regulating T regulatory cells (157,158), and anti-inflammatory effects (159)(160)(161)(162). Generally they are essential for the health and well-being of the host when present in sufficient amounts (163). Studies showed that Lactobacillus strains can produce different types of SCFAs. L. rhamnosus GG and L. gasseri PA 16/8 produce propionate (163,164). Moreover, SCFAs have been associated with the beneficial effects of probiotic Lactobacillus strains in some research. Dhaliwal et al. (165) confirmed that supplementation of mice with L. plantarum showed an increase in acetate and butyrate levels and reduced intestinal permeability and monoamine oxidases in the brain. SCFAs-promoting probiotic L. johnsonii L531 treatment have been shown to control Salmonella infection and maintaining metabolic homeostasis in pig (166). In a screening of LAB to reduce cholesterol levels, the strain of L. plantarum CECT 7529, which produced higher quantities of propionic and butyric acids, showed excellent properties for reducing cholesterol levels (167). Furthermore, probiotic strains L. salivarius FP25 and FP35, and L. reuteri NCIMB exhibited inhibitory effect on colon cancer cell proliferation, which was mediated by the production of SCFAs (168,169).

Conjugated linoleic acid (CLA)
Studies showed that many Lactobacillus species are able to synthesize conjugated linoleic acids (CLAs) (170,171). The ability of L. rhamnosus PL60 to produce cis-9, tra-11 and tra-10, cis-12-CLA in humans was the first report indicating that probiotic bacteria produce CLA (172). Further studies showed that some Lactobacilli species isolated from GI tract of human and animals, including L. rhamnosus, L. acidophilus and L. plantarum, are CLA producers (173,174).
CLA inhibited the growth of HT-29 and Caco-2 cancer cell lines in vitro (175). Proliferation of MDAMB-231 cells was inhibited by L. plantarum-produced CLA in a dose dependent manner (176). In vivo administration of CLA to rats could decrease the occurrence of colonic tumors and increase the apoptotic indices (177). Moreover, CLA has been shown to reduce the incidence of colonic, skin, mammary, and prostate carcinogenesis in animal models (178).
CLAs produced by probiotic Lactobacillus have remarkable anti-tumor effect. CLA inhibited the growth of HT-29 and Caco-2 cancer cell lines in vitro (175). Proliferation of MDAMB-231 cells was inhibited by L. plantarum-produced CLA in a dose dependent manner (176). In vivo administration of CLA to rats could decrease the occurrence of colonic tumors and increase the apoptotic indices (177). Moreover, CLA has been shown to reduce the incidence of colonic, skin, mammary, and prostate carcinogenesis in animal models (178).

INTERACTION OF PARAPROBIOTICS AND POSTBIOTICS WITH THEIR RECEPTORS ON HOST CELLS
The beneficial effects of paraprobiotics or postbiotics are mediated through an interaction between the microbial products and host. Probiotic Lactobacilli possess conserved MAMPs, including peptidoglycan, LTA, S-layer protein A (SlpA), EPS, and genomic DNA, which can be recognized by pattern recognition receptors (PRRs), induce downstream signaling cascades that confer the beneficial functions (5).
The importance of Toll-like receptors (TLRs) and Nucleotidebinding oligomerization domain-like receptors (NLRs) in mediating differential host interaction with paraprobiotics and probiotics has been widely acknowledged (107,194). In this review we summarize four types of the PRRs that play principal roles in the regulation of the host's immune response and these different types of PRRs can bind to specific paraprobiotics or postbiotics of Lactobacillus strains (Figure 2).
The EPS of L. delbrueckii TUA4408L can act as TLR2 and TLR4 ligands, and exert anti-inflammatory activities in porcine IECs by modulating MAPK and NF-κB signaling pathways (197). L. plantarum N14 EPS reduced inflammation in intestinal epithelial cells depending on RP105/MD1 complex (a member of TLR family). (101). Similarly, L. rhamnosus GG and its components (surface layer protein and EPS) inhibited MAPK and NFκB signaling and alleviated LPS-induced inflammatory cytokines in porcine intestinal epithelial cells by modulating TLR expressions (204).

Nucleotide-Binding Oligomerization Domain-Like Receptors (NLRs)
NLRs constitute a large family of PRRs and includes a number of subfamilies, which can be distinguished depending on the N-terminal effector domains (195). Two well-studied NLR proteins are NOD1 and NOD2. The NOD1 recognizes molecules containing D-Glu-mDAP (205), whereas NOD2 are vital for the regulation of NAM-D-Ala-D-Glu unit of the molecules (206). Recognition of muropeptide from Lactobacilli by NOD2 can induce anti-inflammatory properties and protect mice from colitis development (94). Different types of signaling molecules from Lactobacilli species including the fragments of peptidoglycan were sensed by NODs (207), and this sensing results in the activation of NF-κB and antimicrobial activity (208).

C-Type Lectin-Like Receptors (CTLRs)
CTLRs recognize carbohydrates molecules, through one or more carbohydrate recognition domains (CRDs) (209). The sugar moieties found in the glycan backbone of the bacterial peptidoglycan bind CTLRs (210). After the ligand recognition, specialized CTLRs trigger or inhibit wide ranges of signaling pathways, thus modulate diverse immune responses (211).
DC-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is a CLR expressed mainly on dendritic cells (DCs) and recognizes mannose-and fucose-containing glycans that are present on many species of Lactobacilli bacterial cell surfaces. DC-SIGN was previously shown to bind L. acidophilus SlpA in vitro (200). SlpA-DC-SIGN interaction induced IL-10 production in DCs promoted of T cells that secrete high amounts of IL-4, thereby decreasing the Th1/Th2 ratio (200). Further, in vivo role of the SlpA-induced protective immune regulation was demonstrated (212).

G-Protein-Coupled Receptors (GPCRs)
The best characterized GPCRs are GPR41 and GPR43, which are highly expressed by epithelial cells, adipocytes, enteroendocrine cells and the cells of the sympathetic nervous system (213), and are mainly activated by SCFAs (214). Butyrate and propionate produced by microbiota in the gut acted with GPR43 and regulated the accumulation of Foxp3 + Treg cells (215). The recognition of SCFAs by GPR109A has also been reported. For instance, activation of the GPR109A receptor by butyrate induced the differentiation of regulatory and IL-10-producing T cells, which suppressed colonic inflammation and carcinogenesis by promoting anti-inflammatory properties in colonic macrophages and dendritic cells (216). Furthermore, SCFAs produced by gut  (198,199) NUCLEOTIDE Human cell lines (201); (202) microbiota may regulate lipid metabolism, glucose homeostasis and insulin sensitivity through GPCR signaling (156).

CONCLUSIONS
Paraprobiotics and postbiotics derived from Lactobacillus species consist of a wide range of effector molecules. These products and byproducts of probiotic Lactobacillus have been found to possess magnificent beneficial functions including preservation of epithelial barrier, anti-tumor effect, immunomodulation, and antagonistic effects against pathogens. Furthermore, they have various advantages compared with probiotics, including clear chemical structures and safety dose parameters, as well as longer shelf life (217,218). Therefore, the use of paraprobiotics and postbiotics may represent a valid and safer alternative to live probiotic bacteria, and have exhibited good potential to replace probiotics (219,220). The mechanisms underlying the beneficial effects have been less known, especially the signaling pathways downstream the interaction of paraprobiotics/postbiotics and PRRs, which deserve more investigation. Furthermore, the structure-activity relationship (SAR) of paraprobiotics and postbiotics will be an interesting topic, which may guide the functional improvement of these probiotic components, by either chemical or biological strategies.
Currently the application of postbiotics and paraprobiotics in human food, animal feed and pharmaceutical industries is increasing and several paraprobiotic and postbiotics products derived from Lactobacill species are commercially available for prevention or treatment of some diseases (221)(222)(223)(224)(225). Nevertheless, more evidence is needed to validate the beneficial effects of paraprobiotics and postbiotics. Current advancement of molecular technologies such as multi-omics have been promoting the identification of more paraprobiotics and postbiotics from probiotic Lactobacillus strains. Moreover, novel probiotics from other family or phylum are being discovered and studied, such as commensal bacterium isolated from the intestine of both human and animals (226,227). The techniques and experience of paraprobiotics and postbiotics discovery from probiotic Lactobacilli may guide the investigation of novel functional components derived from the new probiotics. Collectively, paraprobiotics and postbiotics have good potential as prophylatctic or therapeutic agents as well as functional food or feed additives for human or animal use.